Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.70 USD
Change Today -0.35 / -3.17%
Volume 621.1K
AFFX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

affymetrix inc (AFFX) Key Developments

Affymetrix Inc. Appoints Board of Directors

On May 13, 2015, the Board of Directors of Affymetrix elected Riccardo Pigliucci to the Board of Directors of the company and appointed Mr. Pigliucci a member of its Compensation Committee. Mr. Pigliucci will participate in the company's compensation program for non-employee directors, as amended, including an annual retainer of $45,000, and an initial award of options to purchase 30,000 shares of the company's common stock, which will vest and become exercisable in equal installments on each of the first three anniversaries of the date of grant, subject to Mr. Pigliucci's continued service on the Board through each vesting date. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP since 2006. Prior to joining Aldwych Associates, LLP and since 2005, he served as an independent consultant. Mr. Pigliucci was Chairman and Chief Executive Officer of Discovery Partners International Inc. from 1998 until 2005. Mr. Pigliucci currently serves as Chairman of the Board of Directors of Medaphor PLC. The Board of Directors values Mr. Pigliucci's experience in the life sciences and healthcare equipment industry. The annual meeting of the stockholders of the company was held on May 13, 2015. At the Meeting, the stockholders elected Frank Witney as nominee as director.

Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM

Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Andy Last, Chief Operating Officer.

Affymetrix Mulls Acquisitions

Affymetrix Inc. (NasdaqGS:AFFX) is seeking acquisitions. Andy Last, Executive Vice President, said, "Strengthening our balance sheet to stage us for what we are now in, which we are calling our Phase 3 of our roadmap beginning of this year, where we wish to, obviously, deliver sustainable, profitable growth, and then expand in our market segments of choice and increase our ability to make small tuck-ins and acquisitions."

Affymetrix Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Affymetrix Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $88,717,000 compared to $82,971,000 a year ago. Income from operations was $7,285,000 compared to loss from operations of $8,742,000 a year ago. Income before income taxes was $5,129,000 compared to loss before income taxes of $10,202,000 a year ago. Net income was $4,386,000 compared to net loss of $10,474,000 a year ago. Basic and diluted net income per share was $0.06 compared to basic and diluted net loss per share of $0.14 a year ago. Basic and diluted Non-GAAP net income was $7,884,000 compared to $1,904,000 a year ago. Basic and diluted Non-GAAP net income per share was $0.10 compared to $0.03 a year ago. EBITDA was $12,145,000 compared to $3,135,000 a year ago. Adjusted EBITDA was $17,132,000 compared to $12,916,000 a year ago. The company generated cash flow of approximately $1.3 million from operating activities.

Affymetrix Inc. Presents at UBS Global Healthcare Conference, May-19-2015 08:30 AM

Affymetrix Inc. Presents at UBS Global Healthcare Conference, May-19-2015 08:30 AM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Franklin R. Witney, Chief Executive Officer, President and Director, Gavin H. J. Wood, Chief Financial Officer, Principal Accounting Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $10.70 USD -0.35

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fluidigm Corp $23.88 USD -1.52
Foundation Medicine Inc $32.56 USD -1.43
Luminex Corp $17.22 USD -0.47
Sequenom Inc $2.97 USD -0.12
Takara Bio Inc ¥1,358 JPY +17.00
View Industry Companies
 

Industry Analysis

AFFX

Industry Average

Valuation AFFX Industry Range
Price/Earnings 74.9x
Price/Sales 2.3x
Price/Book 2.8x
Price/Cash Flow 77.3x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.